Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2018

USF1 gene polymorphisms may associate with the efficacy and safety of chemotherapy based on paclitaxel and prognosis in the treatment of ovarian cancer
Authors: H. YE, X.J. LIU, Y. HUI, Y.H. LIANG, C.H. LI, Q. WAN
Neoplasma Vol.65, No.1, p.153-160, 2018
doi:10.4149/neo_2018_170322N205
[View Abstract]


Predictors and prognostic implications of clinical decisions in patients with primary high-risk non-muscle-invasive bladder cancer – results of a cross country retrospective study
Authors: S. POLETAJEW, R. BIERNACKI, P. BURACZYNSKI, J. CHOJNACKI, S. CZARNIECKI, D. GAJEWSKA, T. POHABA, J. SONDKA-MIGDALSKA, M. SKRZYPCZYK, T. SUCHOJAD, D. WOJTKOWIAK, B. ZAFOREMSKI, L. ZAPALA, A. ZEMLA, P. RADZISZEWSKI
Neoplasma Vol.65, No.1, p.147-152, 2018
doi:10.4149/neo_2018_170217N123
[View Abstract]


PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy
Authors: M. VRANKAR, M. ZWITTER, I. KERN, K. STANIC
Neoplasma Vol.65, No.1, p.140-146, 2018
doi:10.4149/neo_2018_170206N77
[View Abstract]


Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion
Authors: N. KOYAMA, Y. WATANABE, Y. IWAI, C. MIWA, Y. NAGAI, K. AOSHIBA, H. NAKAMURA
Neoplasma Vol.65, No.1, p.132-139, 2018
doi:10.4149/neo_2018_170206N78
Price: free access
[View Abstract]


Pitfalls of Contrast Enhanced Ultrasound (CEUS) in determination of breast tumor biological dignity
Authors: V. LEHOTSKA, K. RAUOVA, L. VANOVCANOVA
Neoplasma Vol.65, No.1, p.124-131, 2018
doi:10.4149/neo_2018_170116N43
[View Abstract]


Analysis of DNA methylation and microRNA expression in NUT (nuclear protein in testis) midline carcinoma of the sinonasal tract: a clinicopathological, immunohistochemical and molecular genetic study
Authors: J. LACO, H. KOVARIKOVA, M. CHMELAROVA, H. VOSMIKOVA, K. SIEGLOVA, I. BUBANCOVA, P. DUNDR, K. NEMEJCOVA, J. MICHALEK, P. CELAKOVSKY, R. MOTTL, I. SIRAK, M. VOSMIK, I. MAREK, T. GERYK, J. MEJZLIK, J. SATANKOVA, A. RYSKA
Neoplasma Vol.65, No.1, p.113-123, 2018
doi:10.4149/neo_2018_161122N581
[View Abstract]


Proteomic alterations of fibroblasts induced by ovarian cancer cells reveal potential cancer targets
Authors: X.Y. ZHANG, S.S. HONG, M. ZHANG, Q.Q. CAI, M.X. ZHANG, C.J. XU
Neoplasma Vol.65, No.1, p.104-112, 2018
doi:10.4149/neo_2018_101
[View Abstract]


Integrated analysis of the RNA-Seq data of liver hepatocellular carcinoma
Authors: H. XUE, L. LUO, Y.T. YAO, L.L. WEI, S.P. DENG, X.L. HUANG
Neoplasma Vol.65, No.1, p.97-103, 2018
doi:10.4149/neo_2018_170212N98
[View Abstract]


MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer
Authors: L. GAO, P. YAN, F.F. GUO, H.J. LIU, Z.F. ZHAO
Neoplasma Vol.65, No.1, p.89-96, 2018
doi:10.4149/neo_2018_161128N594
[View Abstract]


KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway
Authors: X. SHEN, L.G. CHANG, M.Y. HU, D. YAN, L.N. ZHOU, Y. MA, S.K. LING, Y.Q. FU, S.Y. ZHANG, B. KONG, P.L. HUANG
Neoplasma Vol.65, No.1, p.81-88, 2018
doi:10.4149/neo_2018_170224N142
[View Abstract]


Targeting RAD50 increases sensitivity to radiotherapy in colorectal cancer cells
Authors: C. CHEN, Y. WANG, J.F. MEI, S.S. LI, H.X. XU, H.P. XIONG, X.H. WANG, X. HE
Neoplasma Vol.65, No.1, p.75-80, 2018
doi:10.4149/neo_2018_170219N128
[View Abstract]


Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma
Authors: S.Q. SHI, J.-J. KE, Q.S. XU, W.Q. WU, Y.Y. WAN
Neoplasma Vol.65, No.1, p.66-74, 2018
doi:10.4149/neo_2018_161215N642
[View Abstract]


RNA interference-mediated silencing of aquaporin (AQP)-5 hinders angiogenesis of colorectal tumor by suppressing the production of vascular endothelial growth factor
Authors: W. WANG, Q. LI, T. YANG, D. LI, F. DING, H. SUN, G. BAI
Neoplasma Vol.65, No.1, p.55-65, 2018
doi:10.4149/neo_2018_161019N487
[View Abstract]


MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression
Authors: T.B. HU, H.S. CHEN, M.Q. CAO, F.D. GUO, X.Y. CHENG, Z.B. HAN, M.Q. LI
Neoplasma Vol.65, No.1, p.49-54, 2018
doi:10.4149/neo_2018_170306N159
[View Abstract]


Beclin1 enhances cisplatin-induced apoptosis via Bcl-2-modulated autophagy in laryngeal carcinoma cells Hep-2
Authors: M. YANG, X.M. YANG, D.H. YIN, Q.L. TANG, L. WANG, C. HUANG, P. LI, S.S. LI
Neoplasma Vol.65, No.1, p.42-48, 2018
doi:10.4149/neo_2018_161102N528
[View Abstract]


CCAAT enhancer binding protein β promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor β
Authors: D. LI, J. LIU, S. HUANG, X. BI, B. WANG, Q. CHEN, H. CHEN, X. PU
Neoplasma Vol.65, No.1, p.34-41, 2018
doi:10.4149/neo_2018_161205N620
[View Abstract]


Triptolide induces mitochondrial apoptosis through modulating dual specificity phosphatase 1/mitogen-activated protein kinases cascade in osteosarcoma cells
Authors: W. QIN, S. LI, Y. MIAO, Q. SHI, Y. WANG, J. LI, Z. CHEN, J. WANG, C. LING
Neoplasma Vol.65, No.1, p.21-33, 2018
doi:10.4149/neo_2018_170109N16
[View Abstract]


Bioinformatic analysis of changes in RNA polymerase II transcription stimulated by estradiol in MCF7 cells
Authors: J. WU, Y. CAI, G. ZHAO
Neoplasma Vol.65, No.1, p.14-20, 2018
doi:10.4149/neo_2018_161214N637
[View Abstract]


MicroRNAs in triple-negative breast cancer
Authors: M. KOLECKOVA, M. JANIKOVA, Z. KOLAR
Neoplasma Vol.65, No.1, p.1-13, 2018
doi:10.4149/neo_2018_170115N36
[View Abstract]





Display #  
Results 101 - 119 of 119

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.